# Alnylam Pharmaceuticals Inc (ALNY) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $502M |
| 2024 | -$177M |
| 2023 | -$282M |
| 2022 | -$785M |
| 2021 | -$709M |
| 2020 | -$828M |
| 2019 | -$939M |
| 2018 | -$815M |
| 2017 | -$500M |
| 2016 | -$425M |
| 2010 | -$44M |
| 2009 | -$48M |
| 2008 | -$28M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2025-09-30 | $368M |
| 2025-06-30 | -$16M |
| 2025-03-31 | $18M |
| 2024-09-30 | -$77M |
| 2024-06-30 | $49M |
| 2024-03-31 | -$43M |
| 2023-09-30 | $214M |
| 2023-06-30 | -$230M |
| 2023-03-31 | -$150M |
| 2022-09-30 | -$258M |
| 2022-06-30 | -$192M |
| 2022-03-31 | -$147M |
| 2021-09-30 | -$182M |
| 2021-06-30 | -$146M |
| 2021-03-31 | -$186M |
| 2020-09-30 | -$225M |
| 2020-06-30 | -$199M |
| 2020-03-31 | -$210M |
| 2019-09-30 | -$216M |
| 2019-06-30 | -$236M |
| 2019-03-31 | -$189M |
| 2018-09-30 | -$255M |
| 2018-06-30 | -$192M |
| 2018-03-31 | -$147M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/ALNY/operating-income)